Ab Science SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
AB Science SA leaves SBF 120 Index and share price falls sharply-DJ
AB Science SA:Leaves SBF 120 Index-DJ.Shares fall sharply on last day on index.
Latest Developments for Ab Science SA
- AB Science DSMB recommends the continuation of phase 3 study of masitinib in progressive forms of multiple sclerosis
- AB Science says DSMB recommends continuation of its phase 3 study of Masitinib in mastocytosis
- AB Science announces publication of results from randomized phase 2 study of masitinib
- AB Science proposes allocation of FY 2013 result and share repurchase program
Latest Key Developments in Pharmaceuticals
- Ablynx NV's anti-Il-6r nanobody partnered with AbbVie Inc demonstrates a bioavailability of more than 80 pct after subcutaneous injection
- Merro Pharmaceutical Co Ltd announces change of accounting policy
- Shanghai Dingli Technology Development (Group) Co Ltd completes fully acquisition of Chenzhou Fengyue Science and Technology Co., Ltd and announces shareholding change
- Share this
- Digg this